Lancoford Pharmaceuticals is committed to sustainable procurement practices that encompass our suppliers and manufacturing partners. We believe that responsible sourcing and ethical conduct are integral to our mission. Here’s how we ensure that commitment:

PSCI Self-Assessment Questionnaire (SAQ): We prioritize transparency and accountability through the Pharmaceutical Supply Chain Initiative (PSCI) Self-Assessment Questionnaire (SAQ). This rigorous evaluation tool helps us assess partners’ environmental and ethical practices, ensuring alignment with our sustainability goals.

Business Code of Conduct and Human Rights: Our partners are expected to adhere to our Business Code of Conduct, which underscores the importance of ethical behavior and respect for human rights. Upholding these principles within our supply chain promotes fair treatment, diversity, and responsible practices.

Ethics and Environmental Stewardship: Our focus on ethical behavior extends beyond compliance. We collaborate with partners who share our commitment to responsible practices, waste reduction, and energy efficiency. This ensures that our entire supply chain reflects our dedication to environmental stewardship.

Shared Commitment to Continuous Improvement: Through open dialogue and cooperation, we work alongside our partners to foster a culture of continuous improvement. Collaborative efforts based on transparency and mutual respect enable us to collectively enhance sustainability practices.

Positive Impact on Global Healthcare: By upholding sustainable procurement practices, including adherence to the PSCI SAQ, Business Code of Conduct, and human rights principles, we contribute to a more ethical and sustainable pharmaceutical industry. Our efforts echo our commitment to delivering responsible healthcare solutions that positively impact patients and the environment alike.